Advertisement
Screener

CuraScientific Corp. Increase (Decrease) in Derivative Liabilities

CuraScientific Corp. Increase (Decrease) in Derivative Liabilities

CuraScientific Corp. reported Increase (Decrease) in Derivative Liabilities of $235.71 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-12-08.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2023-12-08

  • CuraScientific Corp. increase (decrease) in derivative liabilities for the quarter ending 2023-09-30 was $235.71K, a 73.22% decline year-over-year.
  • CuraScientific Corp. increase (decrease) in derivative liabilities for the quarter ending 2023-06-30 was $218.89K.
  • CuraScientific Corp. increase (decrease) in derivative liabilities for the quarter ending 2023-03-31 was -$811.56K, a 132.73% decline year-over-year.
  • CuraScientific Corp. increase (decrease) in derivative liabilities for the quarter ending 2022-12-31 was -$3.15M, a 186.39% decline year-over-year.
  • CuraScientific Corp. increase (decrease) in derivative liabilities for fiscal 2022 was -$1.91M, a 197.58% decline from fiscal 2021.
  • CuraScientific Corp. increase (decrease) in derivative liabilities for fiscal 2021 was $1.96M.
  • CuraScientific Corp. increase (decrease) in derivative liabilities for fiscal 2020 was -$2.04M.
Period endIncrease (Decrease) in Derivative Liabilities 3 monthIncrease (Decrease) in Derivative Liabilities 3 month as first filedIncrease (Decrease) in Derivative Liabilities 6 monthIncrease (Decrease) in Derivative Liabilities 9 monthIncrease (Decrease) in Derivative Liabilities 12 month
2023-09-30$235.71K
10-Q · filed 2023-12-08
$454.60K
derived: sum of 2 quarters · filed 2023-12-08
-$356.96K
10-Q · filed 2023-12-08
-$3.50M
derived: sum of 4 quarters · filed 2023-12-08
2023-06-30$218.89K
10-Q · filed 2023-08-21
-$592.67K
10-Q · filed 2023-08-21
-$3.74M
derived: sum of 3 quarters · filed 2023-08-21
-$2.86M
derived: sum of 4 quarters · filed 2023-12-08
2023-03-31-$811.56K
10-Q · filed 2023-05-12
-$3.96M
derived: sum of 2 quarters · filed 2023-05-12
-$3.08M
derived: sum of 3 quarters · filed 2023-12-08
-$5.20M
derived: sum of 4 quarters · filed 2023-12-08
2022-12-31-$3.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17
-$2.27M
derived: sum of 2 quarters · filed 2023-12-08
-$4.39M
derived: sum of 3 quarters · filed 2023-12-08
-$1.91M
10-K · filed 2023-04-17
2022-09-30$880.19K
10-Q · filed 2023-12-08
-$1.24M
derived: sum of 2 quarters · filed 2023-12-08
$1.24M
10-Q · filed 2023-12-08
$4.88M
derived: sum of 4 quarters · filed 2023-12-08
2022-06-30-$2.12M
10-Q · filed 2023-08-21
$359.21K
10-Q · filed 2023-08-21
$4.00M
derived: sum of 3 quarters · filed 2023-08-21
$4.49M
derived: sum of 4 quarters · filed 2023-08-21
2022-03-31$2.48M
10-Q · filed 2023-05-12
-$2.48M
10-Q · filed 2022-05-16
$6.12M
derived: sum of 2 quarters · filed 2023-05-12
$6.61M
derived: sum of 3 quarters · filed 2023-05-12
$6.34M
derived: sum of 4 quarters · filed 2023-05-12
2021-12-31$3.64M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17
$4.14M
derived: sum of 2 quarters · filed 2023-04-17
$3.86M
derived: sum of 3 quarters · filed 2023-04-17
$1.96M
10-K · filed 2023-04-17
2021-09-30$491.82K
10-Q · filed 2022-11-14
$216.29K
derived: sum of 2 quarters · filed 2022-11-14
-$1.69M
10-Q · filed 2022-11-14
2021-06-30-$275.53K
10-Q · filed 2022-08-02
-$2.18M
10-Q · filed 2022-08-02
2021-03-31$1.90M
10-Q · filed 2022-05-16
2020-12-31-$2.04M
10-K · filed 2022-04-14